Hematologist, Oncologist

Saad Z. Usmani, MD

Saad Zafar Usmani joined Levine Cancer Institute as the Director of Plasma Cell Disorder Program and the Director of Clinical Research in Hematologic Malignancies…

Subscribe to

RNAi Explained

Dr. Bersell explores RNA interference (RNAi) technology and its applications in treating ATTR-CM and ATTR-PN. Learn about mechanism of action, clinical evidence, and patient outcomes.

Learn More

Expert Perspectives on Attruby®

Dr. Barry Trachtenberg and ATTR community members discuss Attruby™ (acoramidis), covering clinical data, patient perspectives, and treatment considerations.

Watch Discussion